In this issue of Circulation, Davey Smith and colleagues1 report the association of intermittent claudication with subsequent mortality among more than 18,000 men in the Whitehall Study. Intermittent claudication was assessed by self-administration of the brief and simple London School of Hygiene and Tropical Medicine questionnaire, better known as the Rose Questionnaire after its author.2 This questionnaire is the epidemiological standard for assessment of angina, infarction pain, and intermittent claudication.
of misclassification due mostly to this low sensitivity, we anticipated that large-vessel PAD measured noninvasively would show a better association with mortality; indeed, the relative risk of 1.9 in our study for Rose claudication was nearly quadrupled to 7.5 when large-vessel PAD measured noninvasively was used to predict subsequent mortality.8 After adjustment for other risk factors and exclusion of prevalent disease at baseline, the relative risk of large-vessel PAD for mortality was 4.5.
Interestingly, after exclusion of subjects with baseline ischemia in the Whitehall Study, the association of "possible" claudication (or exercise calf pain that could disappear while walking) with mortality was stronger than the association for probable claudication. We had earlier reported that defining claudication as any exercise calf pain not present at rest (i.e., possible or probable claudication) doubled the sensitivity for large-vessel PAD,9 albeit at the expense of some loss of specificity and positive predictive value, and, interestingly, doubled the relative risk of claudication for subsequent mortality. men and women indicating that the risk of coronary heart disease mortality for those reporting any chest pain on exertion was higher than that for those whose symptoms met the Rose criteria for angina. 10 Thus, similar to the results for possible claudication above, inclusion of "atypical" exertional chest pain in the angina group improved the prediction for subsequent mortality. On a cautionary note, the Rose questionnaire is a short, standardized assessment, and in a more extensive interview the clinician might be able to classify true claudication (or angina) with greater accuracy, but clinicians must be aware that claudication and angina may be atypical.
The old lesson to be emphasized is that largevessel PAD has a remarkable ability, whether defined somewhat crudely by claudication or sharply by noninvasive testing, to predict subsequent cardiovascular mortality, independent of both other cardiovascular risk factors and prevalent disease at baseline. In addition, large-vessel PAD has been shown to be one of the strongest independent predictors of subsequent mortality in both post-myocardial infarction
The opinions expressed in this editorial comment are not necessarily those of the editors or of the American Heart Association. patients11 and post-coronary artery bypass patients.12 It has been recommended that patients being considered for large-vessel PAD surgery have coronary angiography first and bypass surgery when appropriate because of the otherwise poor postoperative survival,'3 although recent evidence suggests preoperative electrocardiographical monitoring for ischemia in large-vessel PAD patients may delineate the high-risk group.14 Notably, the predictive power of claudication for mortality was comparable to that of angina in the Whitehall Study, and the predictive power of noninvasively measured PAD for mortality in the PAD study from our institution8 rivaled that for exercise electrocardiography in published reports. 15 The 
